| answer text |
<p>Pre-exposure prophylaxis (PrEP) plays an important role in preventing HIV transmission.
Currently, PrEP is funded through the three-year PrEP Impact Trial. A core function
of the PrEP Impact Trial Community Advisory Board (CAB) is to raise awareness and
uptake of PrEP in key populations including black, Asian and minority ethnic communities.
Further information about PrEP Impact Trial CAB activities and participating community
groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/"
target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p>
</p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>
</p><p>In addition, Public Health England’s Innovation Fund has supported a number
of community based projects aimed at increasing PrEP awareness in women, BAME groups
and trans communities; information on the projects funded in 2018 can be found at
the following link:</p><p> </p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018"
target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>
</p><p> </p><p> </p>
|
|
